GPC1 and benign breast phyllodes tumor: Zhou’s study (36) showed that GPC-1 in total serum could distinguish patients with early-stage PDAC from HCs, BPT patients and CP patients with an AUC of 0.756, which was lower than that of CA19-9 with an AUC of 0.881.